Researchers have identified new molecules that kill cancer cells while protecting healthy cells and that could be used to treat a variety of different cancers. The research shines a light on what happens to cells at the moment they become cancerous.
The research and pre-clinical trial results were published this month as an open access article in EBioMedicine, a new joint research-clinical journal from the editors of Cell and The Lancet.
Professor Qing-Bin Lu, from the University of Waterloos Faculty of Science, initiated a novel molecular-mechanism-based program to discover a new class of non-platinum-based-halogenated molecules that kill cancer cells, yet prevent healthy cells from being damaged.
The most effective cancer drugs today may kill cancer cells, but they also kill healthy cells, causing severe side effects for patients in the process.
Femtosecond time-resolved laser spectroscopy is a technique traditionally applied to study chemical reactions as they occur on a molecular level. The laser takes a series of rapid snapshots of molecules as they interact and change structure over time. The technique is part of a potential new field of science developed by Professor Lu called femtomedicine (FMD), which integrats the ultrafast laser with molecular biology and cell biology.
Professor Lu has applied the tool to understand the molecular mechanisms that cause cancer at the very moment when the DNA becomes damaged. He has also used it to investigate how radiation therapy and chemotherapy using chemical agents, in particular the widely used platinum chemotherapeutic Cisplatin, work in treating a variety of cancers.
We know DNA damage is the initial step, said Professor Lu. With the novel femtomedicine approach we can go back to the very beginning to find out what causes DNA damage in the first place, then mutation, and then cancer.
By understanding more about the fundamental mechanisms of the diseases, Professor Lu pre-selected molecules most likely to be effective as anti-cancer agents. In this case, he discovered a new family of non-platinum-based molecules similar in structure to Cisplatin but containing no toxic platinum.
Pre-clinical studies with various cultured human cells as well as on rodents show that these new molecules are effective against cervical, breast, ovarian, and lung cancers.
Cisplatin, discovered more than 40 years ago, is an important, widely used platinum-based anti-cancer agent. Unfortunately, the inclusion of platinum in the molecule causes serious side effects like neurotoxicity, kidney damage, hearing loss, nausea and vomiting.
It is extremely rare to discover anti-cancer agents that can selectively kill cancer cells and protect healthy cells, as well as being effective in treating many different types of cancer and having a novel molecular mechanism of action. These candidate drugs should have a high potential to pass through clinical trials and could ultimately save lives, said Professor Lu.
Professor Lu has already applied for patents on the new family of non-platinum-based-halogenated molecules that he has discovered and hopes to start clinical trials soon.
The papers co-authors include Professor Lus team members from Waterloo Qin-Rong Zhang, Ning Ou, Chun-Rong Wang, and Jenny Warrington. Professor Lu is a University Research Chair in the Department of Physics and Astronomy and holds cross-appointments in the departments of Biology and Chemistry.
In just half a century, the University of Waterloo, located at the heart of Canada's technology hub, has become one of Canada's leading comprehensive universities with 35,000 full- and part-time students in undergraduate and graduate programs. A globally focused institution, celebrated as Canadas most innovative university for 23 consecutive years, Waterloo is home to the world's largest post-secondary co-operative education program and encourages enterprising partnerships in learning, research and discovery. In the next decade, the university is committed to building a better future for Canada and the world by championing innovation and collaboration to create solutions relevant to the needs of today and tomorrow. For more information about Waterloo, please visit uwaterloo.ca.
-30-
Nick Manning University of Waterloo 519-888-4451 226-929-7627 http://www.uwaterloo.ca/news @uWaterlooNews
Attention broadcasters: Waterloo has facilities to provide broadcast quality audio and video feeds with a double-ender studio. Please contact us to book.
Read more:
Waterloo researcher discovers molecules that could kill ...
- Making Headway in the Eye Transplant Field - June 15th, 2012 [June 8th, 2012]
- The Best of Ophthalmology.....EyeWorld News Magazine - November 24th, 2013 [November 24th, 2013]
- Dr Parwez Hossain | University of Southampton - November 24th, 2013 [November 24th, 2013]
- Diagnostic, Medical Aesthetic, Ophthalmic & Surgical Equipment ... - November 24th, 2013 [November 24th, 2013]
- David Gracias - Department of Chemical and Biomolecular ... - November 24th, 2013 [November 24th, 2013]
- Fem pH: Indications, Side Effects, Warnings - Drugs.com - January 3rd, 2014 [January 3rd, 2014]
- Femtomedicine the new frontier of biomedical sciences - April 14th, 2014 [April 14th, 2014]
- femtomedicine.com - July 23rd, 2014 [July 23rd, 2014]
- Emergence of Femtomedicine - New Frontier of Biomed ... - October 2nd, 2014 [October 2nd, 2014]
- NJIT: News : NJIT in the news - New Jersey - October 27th, 2014 [October 27th, 2014]
- goddess-kicks.com - W3Snoop - November 5th, 2014 [November 5th, 2014]
- Nominees | Vidovdan in Philadelphia 2015! - January 14th, 2015 [January 14th, 2015]
- Frontiers | The antioxidants dilemma: are they potentially ... - February 8th, 2015 [February 8th, 2015]
- Ideas, Inventions And Innovations - May 21st, 2015 [May 21st, 2015]
- Visualizing Light at Trillion FPS, Camera Culture, MIT ... - June 10th, 2015 [June 10th, 2015]
- Femtomedicine Process Kills Cancer Cells, Protects Healthy ... - June 10th, 2015 [June 10th, 2015]
- Think Twice Before Eating That Ham Sandwich Or Triple Meat ... - June 15th, 2015 [June 15th, 2015]
- In Vitro and In Vivo Studies of Non-Platinum-Based ... - June 18th, 2015 [June 18th, 2015]
- Femto Medicine | Femto Medicine News - July 1st, 2015 [July 1st, 2015]
- MTB Europe biotechnology news - July 3rd, 2015 [July 3rd, 2015]
- Scientists discover new molecules that kill ... - EurekAlert! - July 10th, 2015 [July 10th, 2015]
- Femto Medicine | Mayo Clinic In The News - September 9th, 2015 [September 9th, 2015]
- Scientists discover new molecules that kill cancer cells ... - July 12th, 2016 [July 12th, 2016]
- Electron transfer-based combination therapy of cisplatin ... - July 12th, 2016 [July 12th, 2016]
- In Vitro and In Vivo Studies of a New Class of Anticancer ... - July 12th, 2016 [July 12th, 2016]
- Femtocell - Wikipedia, the free encyclopedia - July 12th, 2016 [July 12th, 2016]
- Research in biochemistry and molecular biology | Institute ... - August 27th, 2016 [August 27th, 2016]
- Torrents.fm - October 15th, 2016 [October 15th, 2016]
- Femtomedicine : Femto Medicine | Femto Medicine News - November 24th, 2017 [November 24th, 2017]
- Business Directory - Uptown Waterloo Business Improvement Area - January 13th, 2018 [January 13th, 2018]
- Bladeless LASIK: Femtosecond Laser Eases LASIK Fears - May 6th, 2018 [May 6th, 2018]
- Femtosecond Laser Eases LASIK Fears - June 6th, 2018 [June 6th, 2018]
- Femtocell - Wikipedia - July 5th, 2018 [July 5th, 2018]
- FEMTO-LASIK AT FOCUS TOP-MEDICINE 2018 EUROEYES - November 25th, 2018 [November 25th, 2018]